Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19

Authors:

Abstract
PurposeAutoantibodies (aAbs) to type I interferons (IFNs) have been found in MethodsELISA and ISRE reporter assays were used to detect aAbs and naAbs using E. coli-produced IFNs.ResultsIn an uninfected general Japanese population aged 20–91, we found aAbs in 0.087% of individuals. naAbs to type I IFNs (IFN-α2 and/or IFN-ω, 100 pg/mL) were detected in 10.6% of patients with critical infections, 2.6% of patients with severe infections, and ≤1% of patients with asymptomatic to mild infections. They were higher in COVID-19 patients over 50 (5.8%) than in younger patients (0%) and higher in men (5.5%) than in women (1.1%). A significant but not strong correlation between aAbs and naAbs to IFN-α2 existed (r=-0.307, p-valueConclusionIn the largest study focusing on a single ethnic and geographic group, we show that Japanese individuals with pre-existing naAbs have a much higher risk of life-threatening COVID-19 pneumonia.